A non-interventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma

Trial Profile

A non-interventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2017

At a glance

  • Drugs Trabectedin (Primary)
  • Indications Soft tissue sarcoma
  • Focus Therapeutic Use
  • Acronyms Y-IMAGE
  • Most Recent Events

    • 12 Sep 2017 Results assessing overall versus per country routine real-life use of trabectedin in patients with advanced soft tissue sarcoma across europe, were presented at the 42nd European Society for Medical Oncology Congress.
    • 20 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top